SecBot SecBot
6-K ·Filed Jun 2, 2026

IMTX

Immatics N.V.
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0000950103-26-008259
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine governance filing with no immediate trading catalyst. Monitor the AGM outcome on June 18 for approval of the equity plan and share repurchase authorization, which could signal future capital allocation priorities. No earnings or operational data was released.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$10.04
T+0 close · Jun 2, 2026 · via day close
Latest settled
−6.08%
T+60 · $9.43
Vs SPY
−7.19%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 2 $10.04entry
  2. T+1 · 6mo ago +1.64%α +2.34% · $10.21
  3. T+5 · 5mo ago −8.76%α −5.80% · $9.16
  4. T+20 · 5mo ago −1.89%α −0.33% · $9.85
  5. T+60 · 3mo ago −6.08%α −7.19% · $9.43
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Immatics N.V. filed a 6-K on June 2, 2026, convening its Annual General Meeting (AGM) scheduled for June 18, 2026. The AGM agenda includes routine items such as adoption of statutory annual accounts, discharge of directors, reappointment of three directors (CEO Harpreet Singh, non-executive directors Mathias Hothum and Adam Stone), extension of board authorization for share repurchases, approval of a new 2026 Stock Option and Incentive Plan reserving 6,448,836 shares, and reappointment of PwC as auditor. The filing is a routine governance update with no material financial data or operational catalysts.

Key Facts

  • AGM scheduled for June 18, 2026 in Amsterdam; record date May 21, 2026.
  • Proposed 2026 Stock Option and Incentive Plan reserves 6,448,836 ordinary shares for issuance.
  • Board seeks extension of authorization to repurchase ordinary shares for 18 months at up to 110% of market price.
  • Reappointment of CEO Harpreet Singh as executive director for a 3-year term ending at the 2029 AGM.
  • Reappointment of non-executive directors Mathias Hothum and Adam Stone for 3-year terms.
  • PwC proposed as auditor for FY 2026.
  • No financial results, guidance, or material operational updates were provided in this filing.

Financial Impact

No financial figures reported. The new equity incentive plan authorizes up to 6,448,836 shares (approximately 3-4% dilution based on current share count, but no actual grants have been made).

dilution

Risk Factors

  • Potential future dilution from the 2026 equity incentive plan if fully utilized.
  • No material business or financial updates, stock price movement unlikely from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0000950103-26-008259
Document: dp247175_ex9902.htm0000950103-26-008259
Document: dp247175_ex9901.htm0000950103-26-008259
Document: dp247175_6k.htm0000950103-26-008259
Document: 0000950103-26-008259-index-headers.html0000950103-26-008259
Document: 0000950103-26-008259-index.html0000950103-26-008259
Document: 0000950103-26-008259.txt0000950103-26-008259

Track record

23 reports on IMTX

Performance horizon

8 of 14 bullish or bearish reports moved the stock their way by T+5. Best: +22.12% at T+20 after the May 12, 2026 report. 9 of 14 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $6.24 Now $6.17 −1.12% settles Nov 23
  2. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $6.55 Now $6.17 −5.73% settles Nov 23
  3. Nov 10, 20266d ago 6-K Neutral 5/10 No price data
  4. Nov 10, 20266d ago Press Release Neutral 4/10 Entry $6.42 Now $6.17 −3.89% settles Nov 17
  5. Oct 26, 202621d ago 6-K Bullish 5/10 Entry $7.15 to $7.20 Now $6.17 −13.71% ▲ +0.70% +1.96% vs SPY
  6. Oct 24, 202624d ago Press Release Bullish 6/10 Entry $7.15 to $7.20 Now $6.17 −13.71% ▲ +0.70% +1.96% vs SPY
  7. Oct 23, 202624d ago 6-K Bullish 7/10 Entry $7.31 to $7.20 Now $6.17 −15.60% ▼ −1.50% −0.95% vs SPY
  8. Aug 27, 202611w ago Insider Buy Bullish 6/10 Entry $9.45 to $9.56 Now $6.17 −34.71% ▲ +1.16% +1.05% vs SPY
  9. Aug 26, 202611w ago 6-K Bearish 6/10 Entry $9.36 to $9.46 Now $6.17 +34.08% ▼ −1.07% −0.80% vs SPY
  10. Aug 18, 202612w ago 6-K Neutral 6/10 Entry $9.09 to $9.24 Now $6.17 −32.12% ▲ +1.65% +1.85% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 2, 2026